Leucovorin clinical trials
Also written Folinic acid, Wellcovorin and NSC-3590.
Its developmentBy 21 companies, company by company34 company-led studies, furthest phase 3: when each phase was reached, its deals, target and what is ahead.Counted the way a researcher would: Leucovorin with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.
This browser remembers your choice.
How each study uses Leucovorin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Leucovorin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 20 Jun 1952 · LEUCOVORIN CALCIUM · NDA 008107 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
306 studies that test it; most in 2011 (18)
| Year | Studies |
|---|---|
| 1992 | 2 |
| 1993 | 2 |
| 1994 | 4 |
| 1995 | 2 |
| 1996 | 4 |
| 1997 | 4 |
| 1998 | 2 |
| 1999 | 5 |
| 2000 | 8 |
| 2001 | 4 |
| 2002 | 9 |
| 2003 | 12 |
| 2004 | 12 |
| 2005 | 10 |
| 2006 | 14 |
| 2007 | 7 |
| 2008 | 3 |
| 2009 | 13 |
| 2010 | 11 |
| 2011 | 18 |
| 2012 | 16 |
| 2013 | 9 |
| 2014 | 11 |
| 2015 | 13 |
| 2016 | 8 |
| 2017 | 7 |
| 2018 | 14 |
| 2019 | 14 |
| 2020 | 12 |
| 2021 | 12 |
| 2022 | 5 |
| 2023 | 9 |
| 2024 | 10 |
| 2025 | 10 |
| 2026 | 10 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 34 · Other 275
National Cancer Institute (NCI) (13) · M.D. Anderson Cancer Center (10) · National Health Research Institutes, Taiwan (10) · Children's Oncology Group (9) · University of Miami (7) · Fujian Cancer Hospital (7) · Memorial Sloan Kettering Cancer Center (6) · Alliance for Clinical Trials in Oncology (5)
Often tested with
Tested in the same studies.
Fluorouracil (222) · Oxaliplatin (147) · Irinotecan (84) · Docetaxel (34) · Cisplatin (30) · Capecitabine (27) · Methotrexate (26) · Paclitaxel (24)
Related medicines
As reviewed, each with the page that says it.
- One of Vitamin B Complex source
- Levoleucovorin is one of its enantiomers, counted on its own page source
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Tested against it · 12 phase 3 studies under way
Leucovorin is the comparator. A study of two new drugs counts under both.
- 1Ipilimumab · Bristol-Myers Squibb
- 1Nivolumab · Bristol-Myers Squibb
- 1Daraxonrasib · Revolution Medicines, Inc.
- 1Pembrolizumab · Merck Sharp & Dohme LLC · next primary completion Sep 2028
- 1Tambotatug pelitecan · MediLink Therapeutics (Suzhou) Co., Ltd. · next primary completion Jan 2029
- 1Alveltamig · Suzhou Zelgen Biopharmaceuticals Co.,Ltd · next primary completion Jun 2028
- 1Tinengotinib · TransThera Sciences (Nanjing), Inc. · next primary completion Dec 2029
- 1Sonesitatug vedotin · AstraZeneca · next primary completion Aug 2029
Reaching primary completion within a year · 22, 5 in phase 3
Studies that test Leucovorin, phase 3 first.
- Dec 2026Efficiency of a Composite Personalised Care on Functional Outcome in Early PsychosisPhase 3 · Centre Hospitalier St Anne
- Dec 2026Chemoradiotherapy Followed by Planned Surgery or by Surveillance and Surgery Only When Needed for Oesophageal CancerPhase 3 · Karolinska University Hospital
- Jan 2027Perioperative or Adjuvant mFOLFIRINOX for Resectable Pancreatic CancerPhase 3 · Erasmus Medical Center
- Mar 2027HR070803 in Combination With Oxaliplatin, 5-fluorouracil/LV Versus GX as Adjuvant Therapy for Pancreatic CancerPhase 3 · Fudan University
- Apr 2027Total Neoadjuvant FLOT Chemotherapy in Locally Advanced Gastric and Gastroesophageal Junction CancerPhase 2/3 · Ukrainian Society of Clinical Oncology
- Nov 2026Trial Evaluating 3-year Disease Free Survival in Patients With Locally Advanced Rectal Cancer Treated With Chemoradiation Plus Induction or Consolidation Chemotherapy and Total Mesorectal Excision or Non-operative ManagementPhase 2 · Memorial Sloan Kettering Cancer Center
- Dec 2026Study to Assess Adverse Events and Change in Disease Activity in Previously Treated Adult Participants Receiving Intravenous (IV) ABBV-400 With Unresectable Metastatic Colorectal Cancer in Combination With IV Fluorouracil, Folinic Acid, and BevacizumabPhase 2 · AbbVie
- Jan 2027Organ Preservation With Durvalumab-based Immunotherapy in Combination With Chemoradiation as Definitive Therapy for Early Stage Esophageal Adenocarcinoma With Indication for Radical SurgeryPhase 2 · Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
- Jan 2027Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)Phase 1/2 · National Institute of Allergy and Infectious Diseases (NIAID)
- Jan 2027A Randomized Controlled Study of Serplulimab Combined With Chemotherapy for Locally Advanced Gastric AdenocarcinomaPhase 2 · Guangdong Provincial People's Hospital
Studies
Open first, then newest update. How each study uses Leucovorin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 309
- Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening TrialRecruitingPhase 2National Cancer Institute (NCI)NCT05564377Written as LeucovorinHow we know
- Short Course Radiation Therapy and Combination Chemotherapy for the Treatment of Stage II-III Rectal CancerRecruitingPhase 1Jonsson Comprehensive Cancer CenterNCT04703101Written as LeucovorinHow we know
- A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal AdenocarcinomaRecruitingPhase 2AstraZenecaNCT07069712Written as FLOT ChemotherapyHow we know
- SMAD4 Tailored Neoadjuvant Therapy for the Treatment of Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma, SMART-PANC TrialRecruitingPhase 2Northwestern UniversityNCT07748611Written as LeucovorinHow we know
- Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel CancersRecruitingPhase 2SWOG Cancer Research NetworkNCT04205968Written as LeucovorinHow we know
- Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)RecruitingPhase 1/2National Institute of Allergy and Infectious Diseases (NIAID)NCT03109288Written as LeucovorinHow we know
- NBTXR3, Chemotherapy, and Radiation Therapy for the Treatment of Esophageal CancerRecruitingPhase 1M.D. Anderson Cancer CenterNCT04615013Written as LeucovorinHow we know
- Preoperative Hypofractionated Radiotherapy With FOLFOX for Esophageal or Gastroesophageal Junction AdenocarcinomaRecruitingPhase 2Mayo ClinicNCT06078709Written as Leucovorin CalciumHow we know
- NALIRIFOX Before Surgery for the Treatment of Borderline Resectable Pancreatic Ductal Adenocarcinoma, Nectar TrialRecruitingPhase 2Roswell Park Cancer InstituteNCT06821997Written as Leucovorin CalciumHow we know
- Sintilimab Plus NALIRIFOX or Gemcitabine-Cisplatin as First-Line Treatment for Metastatic Biliary Tract CancerRecruitingPhase 2The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolNCT07831993Written as LeucovorinHow we know
- A Prospective, Open-Label, Randomized Controlled Clinical Study Comparing Hepatic Arterial Infusion Chemotherapy (HAIC) With Capecitabine as Adjuvant Therapy After Radical Surgery for Malignant Biliary Tract TumorsRecruitingPhase 4Zhai WenlongNCT07790445Written as Oxaliplatin + 5-Fluorouracil/LeucovorinHow we know
- Liposomal Irinotecan Plus 5-FU/LV and Sintilimab With Sequential SBRT for Locally Advanced Biliary Tract CancerRecruitingPhase 2The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolNCT07797816Written as LeucovorinHow we know
- PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric CancerRecruitingPhase 1City of Hope Medical CenterNCT04329494Written as LeucovorinHow we know
- mFOLFOX/mFOLFIRI vs. mFOLFOX in Advanced or Recurrent Biliary Tract Cancer Second-lineRecruitingPhase 2Seoul National University Bundang HospitalNCT07062536Written as Oxaliplatin, 5FU, leucovorinHow we know
- Study of NALIRIFOX in Advanced Unresectable Small Bowel TumorsRecruitingPhase 2Tiago Biachi de CastriaNCT06835387Written as LeucovorinHow we know
- Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal CancerRecruitingPhase 3Canadian Cancer Trials GroupNCT06205485Written as LeucovorinHow we know
- Phase Ib/IIa Open-label Study, to Evaluate Safety, Tolerability, and Antitumor Activity of HCB101 in Combination With Multiple Agents in Subjects With Advanced Gastric or Gastro-esophageal (GEJ) AdenocarcinomaNot yet recruitingPhase 1/2Kaohsiung Medical University Chung-Ho Memorial HospitalNCT07680569Written as Oxaliplatin + 5-Fluorouracil/LeucovorinHow we know
- A Placebo-controlled Trial of Folinic Acid in Children With ASDRecruitingPhase 2Prof. Adi AranNCT07642661Written as Folinic AcidHow we know
- Sintilimab Plus FOLFIRI as Second-line Therapy for Patients With HER2-negative Advanced Gastric CancerNot yet recruitingPhase 2Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNCT06365008Written as Sintilimab+irinotecan+leucovorin folinate+fluorouracilHow we know
- Folinic Acid as a Treatment for Autism Spectrum Disorder in ChildrenRecruitingPhase 2KK Women's and Children's HospitalNCT07630506Written as Folinic AcidHow we know
See all 309 studies that test Leucovorin →
Given beside what is tested · 594 — Leucovorin is usual care or a partner of the new treatment
- Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged LeukemiaRecruitingPhase 2National Cancer Institute (NCI)NCT06317662Written as LeucovorinHow we know
- Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP TrialRecruitingPhase 3ECOG-ACRIN Cancer Research GroupNCT05863195Written as LeucovorinHow we know
- 2 Versus 6 Hour Oxaliplatin Infusions in Patients With Gastrointestinal CancersRecruitingPhase 2Emory UniversityNCT03800693Written as LeucovorinHow we know
- Study of Petosemtamab Plus Chemotherapy Versus Cetuximab or Bevacizumab Plus Chemotherapy in RAS and BRAF Wild Type, Recurrent, Unresectable or Metastatic Colorectal Cancer (LiGeR-CRC2)RecruitingPhase 3GenmabNCT07775287Written as Leucovorin (Calcium Folinate)How we know
- Substudy 06C: A Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06)RecruitingPhase 1/2Merck Sharp & Dohme LLCNCT06469944Written as LeucovorinHow we know
- Substudy 06E: Umbrella Study of Combination Therapies in Esophageal Cancer (MK-3475-06E/KEYMAKER-U06)RecruitingPhase 1/2Merck Sharp & Dohme LLCNCT06780111Written as LeucovorinHow we know
- A Study of ASP2138 Given Before Surgery, Then Chemotherapy After Surgery, in People With Pancreatic Ductal CancerRecruitingPhase 1Astellas Pharma Global Development, Inc.NCT07024615Written as LeucovorinHow we know
- A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)RecruitingPhase 3Merck Sharp & Dohme LLCNCT06997497Written as Leucovorin/levofolinate calciumHow we know
- Zimberelimab and Quemliclustat in Combination With Chemotherapy for the Treatment of Patients With Borderline Resectable and Locally Advanced Pancreatic AdenocarcinomaRecruitingPhase 1/2Jonsson Comprehensive Cancer CenterNCT05688215Written as LeucovorinHow we know
- A Study of ASP2138 Together With Chemotherapy and Pembrolizumab in Adults With Gastric CancerRecruitingPhase 3Astellas Pharma Global Development, Inc.NCT07673887Written as Folinic acidHow we know
- A Phase Ib/II Study of GFH276 in Combination With Chemotherapy (± Bevacizumab) or Cetuximab in Patients With RAS-mutant Metastatic Colorectal CancerNot yet recruitingPhase 1/2Genfleet Therapeutics (Shanghai) Inc.NCT07915921Written as LeucovorinHow we know
- Pan Tumor Rollover StudyRecruitingPhase 2Bristol-Myers SquibbNCT03899155Written as LeucovorinHow we know
- Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )RecruitingPhase 3Revolution Medicines, Inc.NCT07621718Written as Leucovorin (Calcium Folinate)How we know
- A Study of Neoadjuvant-adjuvant Durvalumab and FLOT Chemotherapy Followed by Adjuvant Durvalumab in Chinese Patients With Resectable GC/GEJC.RecruitingPhase 3AstraZenecaNCT07877818Written as FLOT ChemotherapyHow we know
- Tovecimig Plus FOLFIRI in Second Line Metastatic Colorectal CancerNot yet recruitingPhase 2Washington University School of MedicineNCT07662031Written as LeucovorinHow we know
- A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric CancerRecruitingPhase 3Astellas Pharma Global Development, Inc.NCT06901531Written as Folinic acid (leucovorin or local equivalent)How we know
- Pressurized Intraperitoneal Aerosolized Chemotherapy With Mitomycin for the Treatment of Unresectable Appendix or Colorectal Cancer With Peritoneal Metastases, The IMPACT TrialRecruitingPhase 3City of Hope Medical CenterNCT07271355Written as Leucovorin CalciumHow we know
- A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid TumorsRecruitingPhase 1PfizerNCT07318805Written as LeucovorinHow we know
- A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System LymphomaRecruitingPhase 2Juno Therapeutics, Inc., a Bristol-Myers Squibb CompanyNCT07015242Written as Calcium folinateHow we know
- Neoadjuvant Intra-tumoral RP2 and FLOT in Gastroesophageal AdenocarcinomaNot yet recruitingPhase 2Abramson Cancer Center at Penn MedicineNCT07059611Written as LeucovorinHow we know
Showing 20 of 594.
As the comparator · 47 — what is tested is compared with Leucovorin
- A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal CancerRecruitingPhase 1/2Janssen Research & Development, LLCNCT05379595Written as LeucovorinHow we know
- FOLFOX8 Versus mFOLFOX6 With Bevacizumab or Cetuximab for First-Line Unresectable Metastatic Colorectal Cancer (Phase II)Not yet recruitingPhase 2Sun Yat-sen UniversityNCT07621497Written as Calcium FolinateHow we know
- Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2RecruitingPhase 3AstraZenecaNCT07431281Written as LeucovorinHow we know
- Gemcitabine Plus Nab-paclitaxel as Switch Maintenance Versus Continuation of Modified FOLFIRINOX as 1st Line Chemotherapy in Patients With Advanced Pancreatic Cancer.RecruitingPhase 3Gruppo Oncologico del Nord-OvestNCT06897644Written as LeucovorinHow we know
- A Study to Compare the Efficacy and Safety of YL201 With Standard Chemotherapy in Patients With Metastatic Pancreatic Cancer After Failure of Gemcitabine-Based Systemic ChemotherapyNot yet recruitingPhase 3MediLink Therapeutics (Suzhou) Co., Ltd.NCT07803783Written as LeucovorinHow we know
- Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic CancerRecruitingPhase 3NRG OncologyNCT06958328Written as Leucovorin CalciumHow we know
- A Study of ZG006 for Injection Versus Investigator-Selected Chemotherapy in Participants With Advanced Neuroendocrine CarcinomaNot yet recruitingPhase 3Suzhou Zelgen Biopharmaceuticals Co.,LtdNCT07595913Written as 5-fluorouracil, Calcium folinate and IrinotecanHow we know
- Neoadjuvant/Adjuvant AK104 in Microsatellite Instability-high or Mismatch Repair-deficient, Resectable Colon CancerRecruitingPhase 3AkesoNCT07412613Written as Calcium FolinateHow we know
- Efficacy and Safety of TT-00420 (Tinengotinib) Tablets Versus Chemotherapy in Patients With Advanced Intrahepatic Cholangiocarcinoma Harboring FGFR2 Fusions/Rearrangements or MutationsNot yet recruitingPhase 3TransThera Sciences (Nanjing), Inc.NCT07328919Written as Oxaliplatin, fluorouracil, calcium folinate, irinotecan, capecitabineHow we know
- Liposomal Irinotecan + Oxaliplatin + Bevacizumab Versus Liposomal Irinotecan + 5-FU/LVRecruitingPhase 1/2Dai, GuanghaiNCT06782685Written as LVHow we know
- NaliCap (Irinotecan Liposome (Nal-IRI)/Capecitabine) vs. NAPOLI (Nal-IRI/5-FU/LV) ) in Advanced Pancreatic CancerRecruitingPhase 2Seoul National University HospitalNCT04371224Written as LeucovorinHow we know
- A Phase 3 Study to Evaluate Surufatinib Plus Toripalimab in the Treatment of Advanced Neuroendocrine CarcinomaRecruitingPhase 3Hutchison Medipharma LimitedNCT05015621Written as 5-fluorouracil, Calcium folinate and IrinotecanHow we know
- Combination Immunotherapy Plus Standard-of-Care Chemotherapy Versus Standard-of-Care Chemotherapy for the Treatment of Locally Advanced or Metastatic Pancreatic CancerActive, not recruitingPhase 2ImmunityBio, Inc.NCT04390399Written as LeucovorinHow we know
- A Study of Nivolumab, Nivolumab Plus Ipilimumab, or Investigator's Choice Chemotherapy for the Treatment of Participants With Deficient Mismatch Repair (dMMR)/Microsatellite Instability High (MSI-H) Metastatic Colorectal Cancer (mCRC)Active, not recruitingPhase 3Bristol-Myers SquibbNCT04008030Written as LeucovorinHow we know
- Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and AdolescentsActive, not recruitingPhase 3Dana-Farber Cancer InstituteNCT03020030Written as LEUCOVORIN CALCIUMHow we know
- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic LymphomaCompletedPhase 3National Cancer Institute (NCI)NCT00408005Written as Leucovorin CalciumHow we know
- Phase 3 Study of Daraxonrasib (RMC-6236) in Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)Active, not recruitingPhase 3Revolution Medicines, Inc.NCT06625320Written as leucovorinHow we know
- Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Chinese Participants With Stage IV Colorectal Cancer (MK-3475-C66)Active, not recruitingPhase 3Merck Sharp & Dohme LLCNCT05239741Written as LeucovorinHow we know
- A Study of Multiple Immunotherapy-Based Treatment Combinations in Participants With Metastatic Pancreatic Ductal Adenocarcinoma (Morpheus-Pancreatic Cancer)CompletedPhase 1/2Hoffmann-La RocheNCT03193190Written as LeucovorinHow we know
- Efficacy and Safety of Olaparib (MK-7339) With or Without Bevacizumab Compared to Bevacizumab With a Fluoropyrimidine in Unresectable or Metastatic Colorectal Cancer (CRC) (MK-7339-003/LYNK-003)CompletedPhase 3Merck Sharp & Dohme LLCNCT04456699Written as Leucovorin/ levoleucovorinHow we know
Showing 20 of 47.
What changed recently
From the registry's own updates since Oct 21, 2026.
Started recruiting1
Results posted3
- Onvansertib in Combination With Nanoliposomal Irinotecan, Leucovorin, and Fluorouracil for Second-Line Treatment of Participants With Metastatic Pancreatic Ductal AdenocarcinomaNov 4, 2026NCT04752696
- NAPOLI-2: Fluorouracil, Leucovorin, and Nanoliposomal Irinotecan in Biliary CancerOct 27, 2026NCT04005339
- FOLFIRINOX With Digoxin in Patients With Resectable Pancreatic CancerOct 21, 2026NCT04141995
Codes
What other systems call Leucovorin · ClinicalTrials.gg INT007224
- MeSH (NLM) D002955LeucovorinConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) Q573I9DVLPLEUCOVORINConfirmed FDA, NLM
- RxNorm 6313One source FDA
- NCI Thesaurus C71631LeucovorinOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D002955 | Leucovorin | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | Q573I9DVLP | LEUCOVORIN | Confirmed FDA, NLM |
| RxNorm | 6313 | — | One source FDA |
| NCI Thesaurus | C71631 | Leucovorin | One source FDA |
Also registered as leucovorin calcium (UNII RPR1R4C0P4 · RxNorm 225852) and leucovorin calcium pentahydrate (UNII R3W57OBQ5W).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.